Larynx preservation, state of the art;La préservation laryngée, état de la question

Cancer/Radiotherapie

Volumn 9, Issue 1, 2005, Pages 37-41

  Lefebvre, J L ^a   Calais, G ^b  

^a CENTRE OSCAR LAMBRET   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Chemotherapy; Hypopharynx; Larynx; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; PLATINUM; TAXANE DERIVATIVE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVAL; DISEASE COURSE; HEAD AND NECK SURGERY; HUMAN; LARYNGECTOMY; LARYNX CANCER; LARYNX SURGERY; LASER SURGERY; LOW LEVEL LASER THERAPY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REVIEW; TREATMENT OUTCOME;

EID: 15944414565     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2004.12.007     Document Type: Short Survey

References (22)

1. J. Bonner, P. Harari, J. Giralt, N. Azarnia, R. Cohen, D. Raben for the Erbitux™ Head/neck Study group Cetuximab (Erbitux™) prolongs survival in patients with locally advanced squamous cell carcinoma of the head and neck: a phase III study of high dose radiation therapy with or without Cetuximab (abstract, p. 4895) Proc Am Soc Clin Oncol 2004 22:145
2. J. Bourhis, C. Armand, J. Pignon on behalf of the MACH-NC Collaborative Group Proceedings 6th International Conference on Head and Neck Cancer, Washington August 2004
3. D. Chevalier, and J.J. Piquet Subtotal laryngectomy with cricohyoidopexy for supraglottic carcinoma: Review of 61 cases Am. J. Surg. 168 1994 472 473
4. S. Dische, M.I. Saunders, A. Barrett, A. Harvey, D. Gibson, and M.A. Parmar A randomized multicentre trial of CHART vs conventional radiotherapy in head and neck cancer Radiother. Oncol. 44 1997 123 136
5. A.A. Forastiere, H. Goepfert, M. Maor, T.F. Pajak, R. Weber, and W. Morisson Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N. Engl. J. Med. 349 2003 2091 2098
6. K.K. Fu, T.F. Pajak, A. Trotti, C.U. Jones, S.A. Spencer, and T.L. Phillips A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 Int. J. Radiat. Oncol. Biol. Phys. 48 2000 7 16
7. H. Iro, F. Waldfahrer, A. Altendorf-Hofman, M. Weidenbecher, R. Sauer, and W. Steiner Transoral laser surgery of supraglottic cancer Arch. Otolaryngol. Head Neck Surg. 124 1998 1245 1250
8. O. Laccourreye, A. Merite-Drancy, D. Brasnu, E. Chabardes, R. Cauchois, and M. Menard Hemilaryngopharyngectomy in selected pyriform sinus carcinoma staged as T2 Laryngoscope 103 1993 1373 1379
9. J.L. Lefebvre, D. Chevalier, B. Luboinski, A. Kirkpatrick, L. Collette, and T. Sahmoud Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III study J. Natl. Cancer Inst. 13 1996 890 899
10. J.L. Lefebvre, D. Chevalier, B. Luboinski, L. Traissac, G. Andry, D. de Raucourt for the EORTC Head and Neck Cancer Cooperative Group (HNCCG), Brussels, Belgium Is laryngeal preservation (LP) with induction chemotherapy (ICT) safe in the treatment of hypopharyngeal SCC? Final results of the EORTC 24891 trial (abstract, p. 5955) Proc Am Soc Clin Oncol 2004 22:145
11. J.L. Lefebvre, and D. Chevalier Supracricoid partial laryngectomy E. Myers Advances in Otolaryngology - Head and Neck Surgery 1998 Mosby Saint Louis, USA 1 15 (Volume 12)
12. 2 laser Acta Otolaryngol. Suppl. 527 1997 155 159
13. J. Overgaard, H.S. Hansen, L. Specht, M. Overgaard, C. Grau, and E. Andersen Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trials Lancet 362 2003 933 940
14. J.P. Pignon, J. Bourhis, C. Domenge, L. Desigń on behalf of the MACH-NC Collaborative Group Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data Lancet 355 2000 949 955
15. J.J. Piquet, and D. Chevalier Subtotal laryngectomy with crico-hyoido-epiglotto-pexie for the treatment of extended glottic carcinomas Am. J. Surg. 16 1991 357 361
16. J.M. Richard, H. Sancho-Garnier, J.J. Pessey, B. Luboinski, J.L. Lefebvre, and D. Dehesdin Randomized trial of induction chemotherapy in larynx carcinoma Oral Oncol. 34 1998 224 228
17. H.H. Rudert, and S. Höft Tranoral carbon-dioxide laser resection of hypopharyngeal carcinoma Eur. Arch. Otorhinolaryngol. 260 2003 198 206
18. H.H. Rudert, J.A. Werner, and S. Höft Transoral carbon dioxide laser resection of supraglottic carcinoma Ann Otol Rhinol Laryngol 108 1999 819 827
19. W. Steiner, P. Ambrosch, C.F. Hess, and M. Kron Organ preservation by transoral laser microsurgery in piriform sinus carcinoma Otolaryngol. Head Neck Surg. 124 2001 58
20. The Department of Veterans Affairs Laryngeal Cancer Study Group Induction chemotherapy plus radiation compare with surgery plus radiation in patients with advanced laryngeal cancer N. Engl. J. Med. 324 1991 1685 1690
21. J.B. Vermorken, E. Remenar, C. Van Herpen, J. Germa Lluch, Stewart, T. Gorlia EORTC 24971/TAX 323 A randomized phase III multicenter trial of neoadjuvant Docetaxel (Taxotere®) plus Cisplatin plus 5-fluorouracile in patients with locally advanced unresectable squamous cell carcinoma of the head and neck (SCCHN) Proceedings 40th annual meeting of Am Soc Clin Oncol, New Orleans June 2004
22. 2 laser surgery for carcinoma of the larynx and hypopharynx Head Neck 25 2003 382